New beginnings for this aging superstar...
The two-year partnership between the New York Jets and future Hall of Fame quarterback certainly didn't go as planned.
Rodgers played only four snaps in 2023 before suffering a season-ending Achilles tear. He got healthy for the 2024 season and started every game, but the Jets went 5-12. And there were countless off-field distractions all the while.
Now that the Jets have a new head coach in Aaron Glenn and a new general manager in Darren Mougey, they've already announced their intentions to move on from Rodgers. Barring a shocking last-minute trade, he'll be cut with a post-Jun. 1 designation and the Jets will eat $49 million over the next two years.
Entering his age-41 season, Rodgers may not have any more Most Valuable Player runs in him, but there's still a chance he could put together one last strong season. One NFL writer believes he will get that shot on a last-place team.
On Monday, Sportsnaut's Matt Johnson predicted that Rodgers would sign with the Tennessee Titans, who are likely to move on from two-year starter Will Levis after finishing with the NFL's worst record in 2024.
"Rodgers already has a home in Nashville and his Pat McAfee appearances would likely cause fewer problems in a smaller market. On top of that, the Titans coaching staff is in a situation where significant improvements are needed for jobs to be saved," Johnson wrote.
"Signing Rodgers also allows Tennessee to use the first overall pick on Travis Hunter. It’s a win-win scenario for all parties and it would only be a one-year commitment for the Titans."
In 2024, Rodgers had a 63.0 percent completion rate, 28 touchdowns, and 11 interceptions. The only statistic he set a career-low in was won-loss record, but because of all the baggage that seemingly comes with him at this point in his career, a team has to be fairly desperate to take a shot on him.
The Titans just might be the team with that sort of desperation. Free agency begins on Mar. 12, and Rodgers could make his decision shortly thereafter.